Luye Pharma Group's total assets for Q2 2025 were ¥32.03B, an increase of 8.17% from the previous quarter. HK:2186 total liabilities were ¥15.49B for the fiscal quarter, a 11.76% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.